Literature DB >> 20493717

Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents.

Yong Qian1, Gao-Yuan Ma, Ying Yang, Kui Cheng, Qing-Zhong Zheng, Wen-Jun Mao, Lei Shi, Jing Zhao, Hai-Liang Zhu.   

Abstract

A series of novel dithiocarbamate compounds with the chalcone scaffold have been designed and synthesized, and their biological activities were also evaluated as potential antiproliferation and antitubulin polymerization inhibitors. Compound 2n showed the most potent biological activity in vitro, which inhibited the growth of MCF-7 cells with IC(50) of 0.04+/-0.01 microM and the polymerization of tubulin with IC(50) of 6.8+/-0.6 microM. To understand the tubulin-inhibitor interaction and the selectivity of the most active compound towards tubulin, molecular modeling studies were performed to dock compound 2n into the colchicine binding site, which suggested probable inhibition mechanism. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493717     DOI: 10.1016/j.bmc.2010.04.091

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Synthesis, quantitative structure-property relationship study of novel fluorescence active 2-pyrazolines and application.

Authors:  Adel S Girgis; Altaf H Basta; Houssni El-Saied; Mohamed A Mohamed; Ahmad H Bedair; Ahmad S Salim
Journal:  R Soc Open Sci       Date:  2018-03-14       Impact factor: 2.963

2.  Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1H)-one against Ehrlich ascites carcinoma and sarcoma-180.

Authors:  Dinesh Kumar; Pooja Sharma; Kunal Nepali; Girish Mahajan; Mubashir J Mintoo; Amarinder Singh; Gurpreet Singh; Dilip M Mondhe; Gurdarshan Singh; Subheet K Jain; Girish K Gupta; Fidele Ntie-Kang
Journal:  Heliyon       Date:  2018-06-27

3.  Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents.

Authors:  Yahui Ding; Zhongjin Yang; Weizhi Ge; Beijia Kuang; Junqing Xu; Juan Yang; Yue Chen; Quan Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.